BioMed Research International / 2020 / Article / Tab 4

Research Article

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer

Table 4

Correlation among immunohistochemical markers in clinicopathological factors.

Marker expressionPSAPSCANSE

General preoperative PSA level
PSA
NA0.0870.055
valueNA0.3480.552
PSCA
0.087NA0.641a
value0.348NA<0.001
NSE
0.0550.64aNA
value0.552<0.001NA
Preoperative
PSA
NA-0.361a-0.372a
valueNA0.0360.030
PSCA
-0.361aNA0.685a
value0.036NA<0.001
NSE
-0.372a0.685aNA
value0.030<0.001NA
Patients with hormone therapy
PSA
NA0.1800.201
valueNA0.3330.279
PSCA
0.180NA0.587a
value0.333NA0.001
NSE
0.2010.587aNA
value0.2790.001NA

Abbreviations: PSA: prostate-specific antigen; PSCA: prostate stem cell antigen; NSE: enolase 2. aCorrelation is significant at the level (test of significance, Spearman correlation).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.